Pharmaceutical and biological industry: more than 60% of enterprises withdraw their applications for clinical self-examination

In July 2015, the self-examination and verification of drug clinical trial data was officially launched. In July 2015, the CFDA issued the "Announcement on the Implementation of the Self-inspection and Verification of Drug Clinical Trial Data", requiring the 1,622 decla...

The vaccine industry is now at an inflection point, focusing on sectoral opportunities

Potential vaccine varieties are successively listed, and the industry opens up room for development The domestic vaccine sector was not valued by the market before, because most of the varieties were low-priced first-class vaccines and severely homogenized second-clas...

Continuously explore opportunities and paths for the international development of biomedicine

[China Pharmaceutical Network Industry News] In recent years, Shenzhen has attached great importance to the cultivation and development of biological and life health industries. In the process of industrial transformation, Pingshan District has seized the opportunity, a...

Last week, the agency concentrated on investigating electronic chemical medicine and biological

Last week (9.18~9.22) a total of 135 listed companies in the two cities disclosed their investigations. From the perspective of industry distribution, the surveyed companies are mainly concentrated in the electronics, chemical, medical and biological industries. Accordi...

Discussing the development of biomedicine, 7 academicians at home and abroad clash with passion

[Opinions of Experts from China Pharmaceutical Network] Recently, 7 academicians from home and abroad, through keynote speeches and theme discussions, discussed the development opportunities and paths of biomedicine under the background of the Guangdong-Hong Kong-Macao ...